A project led by Professor Ruth Cameron at the University of Cambridge.
Cardiovascular disease is the most common cause of death globally. Coronary artery disease (CAD) represents morbidity caused by the narrowing of coronary arteries as a result of deposition of atheromatous plaques within the arterial walls, causing partial or complete restriction of blood supply to the heart. Minimally invasive surgical management of CAD involves the placement of a coronary stent in the narrowed artery to widen its lumen, and restore blood flow to the affected myocardium.
We are developing next-generation smart stents using novel biocompatible, resorbable polymers and manufactured using 3D printing technology. In the long term, personalised, patient specific stents could be manufactured using information from 3D segmentation of the patient's medical images.
This collaboration has the potential to have a major impact on CVD treatment and outcomes.